Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.
about
Role of human papillomaviruses in carcinogenesisRisk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infectionAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerClinical significance of human papillomavirus genotypingCurrent Cervical Carcinoma Screening GuidelinesAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.Precursors in cancer epidemiology: aligning definition and functionHPV clearance and the neglected role of stochasticityp16 Immunohistochemistry Interpretation by Nonpathologists as an Accurate Method for Diagnosing Cervical Precancer and Cancer.Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda.Marginal and mixed-effects models in the analysis of human papillomavirus natural history data.Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.Do clinical data and human papilloma virus genotype influence spontaneous regression in grade I cervical intraepithelial neoplasia?The potential impact of HPV-16 reactivation on prevalence in older Australians.A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein.An evaluation by midwives and gynecologists of treatability of cervical lesions by cryotherapy among human papillomavirus-positive women.Human papillomavirus infection and anxiety: analyses in women with low-grade cervical cytological abnormalities unaware of their infection status.Update on prevention and screening of cervical cancer.Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV studySignature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens.Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervixQuality measurement and benchmarking of HPV vaccination services: a new approach.Safety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine: an open-label phase I clinical trial.Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policiesHPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study.Persistence, clearance and reinfection regarding six high risk human papillomavirus types in Colombian women: a follow-up study.HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays.Human papillomavirus testing in the prevention of cervical cancerSignificance of HPV-58 infection in women who are HPV-positive, cytology-negative and living in a country with a high prevalence of HPV-58 infection.High HPV-51 prevalence in invasive cervical cancers: results of a pre-immunization survey in North Sardinia, Italy.Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer.Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study.Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control studyHuman papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women.Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.A prospective study of age trends of high-risk human papillomavirus infection in rural China.Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus
P2860
Q22305628-6F10B763-17D2-4B31-8E1E-D525A013B33FQ24568227-31836B51-B5DB-431A-9F5C-0210871BD1D8Q24607403-6F5B31FC-F31B-4D00-9FB4-3F3750352D71Q26771981-108337FD-3CCE-4D3F-8CB3-5E7FCB698271Q26799522-B95E4D10-DA5C-43CD-89F6-4460172CBAC4Q26828840-324FA341-5F1F-408D-88D8-400E22FD1144Q28387064-0754D34F-0138-46F0-866D-FC3E9B7999F1Q28652424-C92140E2-7993-4F2D-BA3A-5D57205E302CQ30352388-79A4F866-4FA7-4D1A-BAC1-CA7FA9D88793Q30388952-4460BEC9-336F-4912-BEA7-EEE398869DF4Q33522517-AF33BB6E-5C6B-46D5-B80B-6B6BED3A6674Q33698774-770256BB-2906-413F-9574-72B28B829074Q33718690-EB5E5E5F-EE87-4BFD-8A8E-440392332B94Q33728067-277BE950-2313-4105-901D-B1D4C011CF2EQ33743070-0D087155-BA4E-4E41-B1A2-45F364B07A5BQ33769284-0999FEFB-F0DB-46BD-BEF5-CBF5811865FAQ33793914-B4E124A0-C8B3-400A-82E0-C3C95F22F7AEQ33829192-170A0AA1-A373-4053-87E4-D3D2A58AE604Q33902505-80B6C72C-8AFE-4A90-83A6-6C22AA7C6817Q33940861-B6A62509-D001-4754-80AD-41A4A4D9D28CQ34031269-4A11D3EF-CC72-4861-AF47-EDA14ADA75A2Q34046478-41233DF2-D69E-410D-9D5F-4F258E63ABC4Q34064401-853246D3-F22B-4208-BE31-BBB5DFADBDC4Q34187128-14F16F55-718B-4248-8AEC-4D80CF437BE3Q34271568-588A9D2F-C336-40C3-AB08-9CD16E1FCF44Q34290684-3B49E12B-C8E2-44EA-927E-3A91683374DAQ34370106-C6B6118F-28E3-44E2-9B48-A21F7521DF63Q34448633-A24D8849-8A63-44B6-8FFC-D88B32D9E36BQ34467791-CBDA10C2-D19B-4D7A-9C06-A44335248E31Q34542304-C4CC0975-B35B-4745-90A4-65438191EC06Q34616083-580D1C2D-E1B0-47B8-9CAB-E1964AE709BEQ34625983-3E42E255-B07D-462B-9394-ED05A29B6BEFQ34744071-8F81DF29-9168-4A43-B722-8BF537C440C7Q34763988-5777047A-1386-4D9D-98ED-BBF525747B93Q34764058-5B0FB683-81FB-47C0-ACC7-16475E9F67E7Q34834113-6049F2EA-1F44-413B-B914-22DD4F9CBD32Q34959801-CEBCF272-7BAB-4F71-9B26-7C27E19E4163Q35051454-9C6961AD-78A0-4889-A7AE-CCC8EAC30078Q35100159-3D893CAB-C76B-4731-9F39-7654E0C638A0Q35109451-6432F004-49A2-4BDB-B733-CD15FA4CF2C1
P2860
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Rapid clearance of human papil ...... ocus on persistent infections.
@en
type
label
Rapid clearance of human papil ...... ocus on persistent infections.
@en
prefLabel
Rapid clearance of human papil ...... ocus on persistent infections.
@en
P2093
P2860
P50
P356
P1476
Rapid clearance of human papil ...... ocus on persistent infections.
@en
P2093
Diane Solomon
Philip E Castle
Proyecto Epidemiológico Guanacaste Group
Robert Burk
Rolando Herrero
P2860
P304
P356
10.1093/JNCI/DJN044
P407
P577
2008-03-25T00:00:00Z